Skip to main navigation Skip to search Skip to main content

Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel Disease

  • Apoorva A. Kumar
  • , Natalie Yeo
  • , Max Whittaker
  • , Priya Attra
  • , Thomas R. Barrick
  • , Leslie R. Bridges
  • , Dennis W. Dickson
  • , Margaret M. Esiri
  • , Chad W. Farris
  • , Delyth Graham
  • , Wen Lang Lin
  • , Daniel N. Meijles
  • , Anthony C. Pereira
  • , Gregory Perry
  • , Douglas L. Rosene
  • , Anan B. Shtaya
  • , Tom Van Agtmael
  • , Giovanna Zamboni
  • , Atticus H. Hainsworth

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Cerebral small vessel disease (SVD) is common in older people and causes lacunar stroke and vascular cognitive impairment. Risk factors include old age, hypertension and variants in the genes COL4A1/COL4A2 encoding collagen alpha-1(IV) and alpha-2(IV), here termed collagen-IV, which are core components of the basement membrane. We tested the hypothesis that increased vascular collagen-IV associates with clinical hypertension and with SVD in older persons and with chronic hypertension in young and aged primates and genetically hypertensive rats. Methods: We quantified vascular collagen-IV immunolabeling in small arteries in a cohort of older persons with minimal Alzheimer pathology (N=52; 21F/31M, age 82.8±6.95 years). We also studied archive tissue from young (age range 6.2-8.3 years) and older (17.0-22.7 years) primates (M mulatta) and compared chronically hypertensive animals (18 months aortic stenosis) with normotensives. We also compared genetically hypertensive and normotensive rats (aged 10-12 months). Results: Collagen-IV immunolabeling in cerebral small arteries of older persons was negatively associated with radiological SVD severity (ρ: -0.427, P=0.005) but was not related to history of hypertension. General linear models confirmed the negative association of lower collagen-IV with radiological SVD (P<0.017), including age as a covariate and either clinical hypertension (P<0.030) or neuropathological SVD diagnosis (P<0.022) as fixed factors. Reduced vascular collagen-IV was accompanied by accumulation of fibrillar collagens (types I and III) as indicated by immunogold electron microscopy. In young and aged primates, brain collagen-IV was elevated in older normotensive relative to young normotensive animals (P=0.029) but was not associated with hypertension. Genetically hypertensive rats did not differ from normotensive rats in terms of arterial collagen-IV. Conclusions: Our cross-species data provide novel insight into sporadic SVD pathogenesis, supporting insufficient (rather than excessive) arterial collagen-IV in SVD, accompanied by matrix remodeling with elevated fibrillar collagen deposition. They also indicate that hypertension, a major risk factor for SVD, does not act by causing accumulation of brain vascular collagen-IV.

Original languageEnglish (US)
Pages (from-to)3696-3705
Number of pages10
JournalStroke
Volume53
Issue number12
DOIs
StatePublished - Dec 1 2022

Keywords

  • Alzheimer disease
  • animals
  • collagen
  • hypertension
  • linear models

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Fingerprint

Dive into the research topics of 'Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel Disease'. Together they form a unique fingerprint.

Cite this